Re-evaluation of publicly available gene-expression databases using machine-learning yields a maximum prognostic power in breast cancer.
Ontology highlight
ABSTRACT: Gene expression signatures refer to patterns of gene activities and are used to classify different types of cancer, determine prognosis, and guide treatment decisions. Advancements in high-throughput technology and machine learning have led to improvements to predict a patient's prognosis for different cancer phenotypes. However, computational methods for analyzing signatures have not been used to evaluate their prognostic power. Contention remains on the utility of gene expression signatures for prognosis. The prevalent approaches include random signatures, expert knowledge, and machine learning to construct an improved signature. We unify these approaches to evaluate their prognostic power. Re-evaluation of publicly available gene-expression data from 8 databases with 9 machine-learning
SUBMITTER: Tschodu D
PROVIDER: S-EPMC10556090 | biostudies-literature | 2023 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA